poisar

Stocks · News reference

Netflix Faces South Africa Price Probe, Putting Stock Under Pressure

BenzingaAnusuya Lahiri

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Globenewswire IncHealthex

    HealthEx Empowers Consumers to Bring Their Personal Health History to Muse, Meta’s New Personal AI Agent

    HealthEx launched a connector enabling U.S. consumers to link their medical records to Muse, Meta's new personal AI agent. The integration allows Muse to provide personalized health guidance, track follow-ups, and help users manage health goals by accessing their complete health history through HealthEx's secure platform, with full user control over data sharing.

  2. The Motley FoolLeo Sun

    Vistra Is Down 30% From Its High. Here's What I'd Do Now.

    Vistra's stock has declined nearly 30% from its September 2025 record high of $217.02 to $154, shedding its 'AI premium' due to battery storage facility shutdowns and regulatory challenges from PJM Interconnection. Despite near-term headwinds, analysts expect strong 2026 growth (29% revenue, quadrupling EPS) driven by data center electricity demand. Trading at 15x 2027 earnings with a 0.6% dividend yield, the stock represents a buying opportunity for long-term investors confident in continued AI infrastructure expansion.

  3. The Motley FoolHarsh Chauhan

    Broadcom vs. Marvell: Which Custom AI Chip Stock Is the Better Buy?

    Broadcom and Marvell are leading players in the custom AI chip market, with Broadcom expected to control 60% market share by 2027 versus Marvell's 20-25%. Broadcom demonstrates significantly faster growth with AI chip revenue projected to reach $230 billion by fiscal 2028 and EPS exceeding $30, compared to Marvell's more modest 45-50% annual growth guidance. Despite Marvell's 163% stock gain in 2026, Broadcom's cheaper valuation combined with superior growth trajectory makes it the more attractive investment opportunity.